Aflac Incorporated's recent quarterly earnings fell short of expectations, primarily due to disappointing performance in the Japanese market amid premium pressures and increased competition. While the U.S. segment showed resilience with a 3.5% rise in net earned premiums and a 2.9% increase in sales, Piper Sandler has lowered its price target for Aflac from $130 to $125 in response to these challenges. Despite the tough outlook, Aflac remains committed to shareholder returns, announcing $1.3 billion returned in the first quarter and a solid dividend growth rate.